CHMP recommends five new drugs, reconsiders Eli Lilly’s Kisunla news2025-06-20T18:21:41+00:00June 20th, 2025|Endpoints News|
Pharma companies are weighing how a drug’s IP location could impact tariffsnews2025-06-20T15:38:49+00:00June 20th, 2025|Endpoints News|
UK’s NICE says Alzheimer’s drugs aren’t worth national coveragenews2025-06-20T14:48:34+00:00June 20th, 2025|Endpoints News|
Grail shares jump on study results for cancer testnews2025-06-18T18:40:18+00:00June 18th, 2025|Endpoints News|
Gilead gets groundbreaking FDA approval for twice-yearly HIV prevention shot news2025-06-18T18:39:55+00:00June 18th, 2025|Endpoints News|
Compounders lose case over semaglutide shortagenews2025-06-18T18:32:06+00:00June 18th, 2025|Endpoints News|
CBER head Prasad adds chief medical and scientific officer to his titlenews2025-06-18T16:25:52+00:00June 18th, 2025|Endpoints News|
BIO’s new chair on FDA changes, most favored nation pricing and Chinanews2025-06-18T16:19:09+00:00June 18th, 2025|Endpoints News|
Orphan drug, PBM changes fall out of Trump tax bill in Senate versionnews2025-06-17T18:49:59+00:00June 17th, 2025|Endpoints News|
FDA approves CSL’s prophylactic for severe swelling conditionnews2025-06-17T17:37:23+00:00June 17th, 2025|Endpoints News|
